A brief olfactory test for Alzheimer's disease

  • Jennifer J. Stamps
    Corresponding author at: McKnight Brain Institute, 1149 Newell Drive, Department of Neuroscience, Room L1-100, Gainesville, FL 32611, USA. Tel.: +1 352 514 5311; fax: +1 352 273 5257.
    Department of Neuroscience, The Clinical and Translational Science Institute, University of Florida, College of Medicine, Gainesville, FL, USA
    Search for articles by this author
  • Linda M. Bartoshuk
    Department of Community Dentistry and Behavioral Science, University of Florida, College of Dentistry, Gainesville, FL, USA
    Search for articles by this author
  • Kenneth M. Heilman
    Department of Neurology, The Center for Neuropsychological Studies, University of Florida, College of Medicine, Gainesville, FL, USA
    Search for articles by this author
Published:August 07, 2013DOI:



      The early diagnosis of Alzheimer's disease (AD) may help reduce disability, enhance quality of life, and aid clinical trials. Portions of olfactory cortex are the initial sites of AD pathology and patients with AD often have more degeneration of their left than right hemisphere. Since the olfactory epithelium projects mainly to the ipsilateral olfactory cortex, patients with AD may demonstrate an asymmetrical (left greater than right) decrement of odor detection sensitivity. This retrospective, case-control study assessed a quick olfactory test that may help diagnose AD.


      Participants with probable AD (N = 18), mild cognitive impairment (MCI, N = 24), other causes of dementia (OD, N = 26) and matched controls (OC, N = 26) were tested, with closed eyes, for their ability to detect an odor, one nostril at a time. A container of 14 g of peanut butter was opened, held medially at the bottom of a 30 cm ruler, and moved up 1 cm at a time during the participants' exhale. Upon odor detection, the distance between the subject's nostril and container was measured.


      The mean odor detection distance of AD patients' left nostril (5.1 cm), and not their right (17.4 cm), was significantly less (F(3,90) = 22.28, p < 0.0001) than the other groups. The mean, standard error, and 95% Confidence Interval of the L–R nostril odor detection difference (cm) for AD were −12.4 ± 0.5, (−15.0,−9.8); for MCI were −1.9 ± 1.2, (−4.2,0.4); for OD were 4.8 ± 1.0, (2.6,6.9); and for OC were 0.0 ± 1.4 (−2.2,2.1).


      This non-invasive and inexpensive left–right nostril odor detection test appears to be a sensitive and specific test for probable AD.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Alzheimer's Disease Education & Referral (ADEAR) Center, A service of the National Institute on Aging, National Institute of Health, US Department of Health and Human Services
        Alzheimer's disease fact sheet.
        ([updated, 2012 Nov 26; cited, 2013 March 27]. Available from:)
        • McKhann G.
        • Drachman D.
        • Folstein M.
        • Katzman R.
        • Price D.
        • Stadlan E.M.
        Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease.
        Neurology. 1984; 34: 939-944
        • McKhann G.M.
        • Knopman D.S.
        • Chertkow H.
        • Hyman B.T.
        • Jack Jr., C.R.
        • Kawas C.H.
        • et al.
        The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association work groups on diagnostic guidelines for Alzheimer's disease.
        Alzheimers Dement. May 2011; 7: 263-269
        • Klunk W.E.
        • Engler H.
        • Nordberg A.
        • Wang Y.
        • Blomqvist G.
        • Holt D.P.
        • et al.
        Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B.
        Ann Neurol. Mar 2004; 55: 306-319
        • Blennow K.
        Cerebrospinal fluid biomarkers for Alzheimer's disease.
        NeuroRx. Apr 2004; 1: 213-225
        • Rowe C.C.
        • Villemagne V.L.
        Brain amyloid imaging.
        J Nucl Med. Nov 2011; 52: 1733-1740
        • Irwin D.J.
        • McMillan C.T.
        • Toledo J.B.
        • Arnold S.E.
        • Shaw L.M.
        • Wang L.S.
        • et al.
        Comparison of cerebrospinal fluid levels of Tau and Aβ 1–42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms.
        Arch Neurol. Aug 2012; 69: 1018-1025
        • Allison A.C.
        The secondary olfactory areas in the human brain.
        J Anat. Oct 1954; 88: 481-488
        • Carmichael S.T.
        • Clugnet M.C.
        • Price J.L.
        Central olfactory connections in the macaque monkey.
        J Comp Neurol. Aug 1994; 346: 403-434
        • Ferreyra-Moyano H.
        • Barragan E.
        The olfactory system and Alzheimer's disease.
        Int J Neurosci. Dec 1989; 49: 157-197
        • Price J.L.
        • Davis P.B.
        • Morris J.C.
        • White D.L.
        The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.
        Neurobiol Aging. Jul–Aug 1991; 12: 295-312
        • Braak H.
        • Braak E.
        Staging of Alzheimer's disease-related neurofibrillary changes.
        Neurobiol Aging. May–Jun 1995; 16 ([discussion 278–84]): 271-278
        • Graves A.B.
        • Bowen J.D.
        • Rajaram L.
        • McCormick W.C.
        • McCurry S.M.
        • Schellenberg G.D.
        • et al.
        Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status.
        Neurology. Oct 1999; 53: 1480-1487
        • Tabert M.H.
        • Liu X.
        • Doty R.L.
        • Serby M.
        • Zamora D.
        • Pelton G.H.
        • et al.
        A 10-item smell identification scale related to risk for Alzheimer's disease.
        Ann Neurol. Jul 2005; 58: 155-160
        • Davidson T.M.
        • Murphy C.
        Rapid clinical evaluation of anosmia—the alcohol sniff test.
        Arch Otolaryngol Head Neck Surg. Jun 1997; 123: 591-594
        • Davidson T.M.
        • Freed C.
        • Healy M.P.
        • Murphy C.
        Rapid clinical evaluation of anosmia in children: the alcohol sniff test.
        Ann N Y Acad Sci. Nov 1998; 855: 787-792
        • Shipley M.
        • Ennis M.
        Functional organization of the olfactory system.
        J Neurobiol. May 1999; 30: 123-176
        • Mori K.
        • Nagao H.
        • Yoshihara Y.
        The olfactory bulb: coding and processing of odor molecule information.
        Science. Oct 1999; 286: 711-715
        • Whitwell J.L.
        • Przybelski S.A.
        • Weigand S.D.
        • Knopman D.S.
        • Boeve B.F.
        • Petersen R.C.
        • et al.
        3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
        Brain. Jul 2007; 130: 1777-1786
        • Ferreira L.K.
        • Diniz B.S.
        • Forlenza O.V.
        • Busatto G.F.
        • Zanetti M.V.
        Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies.
        Neurobiol Aging. Oct 2011; 32: 1733-1741
        • Rami L.
        • Solé-Padullés C.
        • Fortea J.
        • Bosch B.
        • Lladó A.
        • Antonell A.
        • et al.
        Applying new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD.
        Int J Geriatr Psychiatry. Feb 2012; 27: 127-134
        • Doty L.
        • Bowers D.
        • Heilman K.M.
        Florida mental status exam for progressive dementia screening.
        Gerontologist. 1990; 30 (Special issue): 20A
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. Nov 1975; 12: 189-198
        • Brandt J.
        The Hopkins verbal learning test: development of a new memory test with six equivalent forms.
        Clin Neuropsychol. 1991; 5: 125-142
        • Kaplan E.F.
        • Goodglass H.
        • Weintraub S.
        The Boston naming test.
        2nd ed. Lea and Febinger, Philadelphia (PA)1983
        • Benton A.L.
        Development of a multilingual aphasia battery: progress and problems.
        J Neurol Sci. 1969; 9: 39-48
        • Benton A.L.
        Gerstmann's syndrome.
        Arch Neurol. 1992; 49: 445-447
        • Petersen R.C.
        • Smith G.E.
        • Waring S.C.
        • Ivnik R.J.
        • Tangalos E.G.
        • Kokmen E.
        Mild cognitive impairment: clinical characterization and outcome.
        Arch Neurol. Mar 1999; 56: 303-308
        • Keppel G.
        • Wickens T.D.
        Design and analysis: a researcher's handbook.
        4th ed. Pearson Prentice Hall, Upper Saddle River (NJ)2004
        • Vandenbroucke J.P.
        • von Elm E.
        • Altman D.G.
        • Gøtzsche P.C.
        • Mulrow C.D.
        • Pocock S.J.
        • et al.
        STROBE initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration.
        Ann Intern Med. Oct 16 2007; 147: W163-W194
        • Hebert L.E.
        • Scherr P.A.
        • McCann J.J.
        • Beckett L.A.
        • Evans D.A.
        Is the risk of developing Alzheimer's disease greater for women than for men?.
        Am J Epidemiol. Jan 2001; 153: 132-136
        • Knupfer L.
        • Spiegel R.
        Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals.
        Int J Geriatr Psychiatry. 1986; 1: 3-14
        • Moberg P.J.
        • Pearlson G.D.
        • Speedie L.J.
        • Lipsey J.R.
        • Strauss M.E.
        • Folstein
        Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases.
        J Clin Exp Neuropsychol. Dec 1987; 9: 650-664
        • Razani J.
        • Murphy C.
        • Davidson T.M.
        • Grant I.
        • McCutchan A.
        Odor sensitivity is impaired in HIV-positive cognitively impaired patients.
        Physiol Behav. Apr–May 1996; 59: 877-881
        • Bailie J.M.
        • Gilbert P.E.
        • Murphy C.
        Odor identification deficits in Lewy body variant of Alzheimer's disease.
        J Int Neuropsychol Soc. 2003; 9: 164-165
        • Hulshoff Pol H.E.
        • Hijman R.
        • Tulleken C.A.
        • Heeren T.J.
        • Schneider N.
        • van Ree J.M.
        Odor discrimination in patients with frontal lobe damage and Korsakoff's syndrome.
        Neuropsychologia. 2002; 40: 888-891
        • Luzzi S.
        • Snowden J.S.
        • Neary D.
        • Coccia M.
        • Provinciali L.
        • Ralph M.A.L.
        Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration.
        Neuropsychologia. Apr 2007; 45: 1823-1831
        • Rahayel S.
        • Frasnelli J.
        • Joubert S.
        The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis.
        Behav Brain Res. Mar 2012; 231: 60-74
        • Mesholam R.I.
        • Moberg P.J.
        • Mahr R.N.
        • Doty R.L.
        Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases.
        Arch Neurol. Jan 1998; 55: 84-90
        • Sun G.H.
        • Raji C.A.
        • MacEachern M.P.
        • Burke J.F.
        Olfactory identification testing as a predictor of the development of Alzheimer's dementia: a systematic review.
        Laryngoscope. Jul 2012; 122: 1455-1462
        • Koss E.
        • Weiffenbach J.M.
        • Haxby J.V.
        • Friedland R.P.
        Olfactory detection and identification performance are dissociated in early Alzheimer's disease.
        Neurology. Aug 1988; 38: 1228-1232
        • Bahar-Fuchs A.
        • Moss S.
        • Rowe C.
        • Savage G.
        Olfactory performance in AD, aMCI, and healthy ageing: a unirhinal approach.
        Chem Senses. Nov 2010; 35: 855-862